Why succinate?
Some SDH-deficient tumours accumulate succinate. The wider proposal was to develop bacteria that could consume extracellular succinate in the tumour environment; my work focused on the molecular engineering behind it.


Molecular biology
Hi, I’m Chloe. Welcome!
I’m a biomedical researcher based in Cardiff, with an MSc in Biomedical Science and experience in molecular diagnostics, microbial engineering and genomics. This is a place to explore my research, get to know me and see the work I’d love to do next.
I’m looking for laboratory and research roles, as well as PhD opportunities in cancer biology, cancer immunology or computationally assisted biomedical research. I’d be happy to hear from you.
You’re invitedStep into my worldA little more about me, away from the laboratoryMSc Biomedical Science · Distinction
Swansea University · Based in Cardiff
Available for research roles
and PhD opportunities
Could bacteria be engineered to consume excess succinate associated with some cancers? My MSc investigated the DNA constructs needed to explore that idea.
Read my full dissertation Read here on the websiteSome SDH-deficient tumours accumulate succinate. The wider proposal was to develop bacteria that could consume extracellular succinate in the tumour environment; my work focused on the molecular engineering behind it.

Salmonella already has machinery for succinate uptake and metabolism, but its activity is tightly regulated. I investigated two targets: dctA for transport and sdhCDAB for oxidation.

DctA carries succinate across the bacterial inner membrane. This was the first target: a transporter gene that could be cloned and checked separately from the enzyme genes.
The second target, sdhCDAB, encodes succinate dehydrogenase. Explore how its four subunits link succinate oxidation to the respiratory chain.
The dctA construct was the verified outcome. I cloned the gene into pLF305, screened candidate plasmids and used sequencing to establish identity and orientation.
PCR and restriction analysis narrowed the candidates; sequencing established which construct I had made. These are the original experimental panels, available to inspect at full size.
The updated showcase reports growth of the pCT1-bearing recombinant with succinate as the sole carbon source, compared with no growth of the parental strain under the same conditions.
This supports utilisation under the reported conditions. It does not establish tumour targeting or an anticancer effect.
Updated showcase · page 4The operon was amplified, but a stable, correct construct was not verified. Sequencing of selected candidates instead identified unrelated E. coli DNA.
Dissertation Results 4.2 · showcase page 5A verified dctA construct and a later reported growth result provide a basis for further study. The sdhCDAB construct remained unverified, and succinate depletion or anticancer activity in a tumour model was not demonstrated.
The practical contribution was building and checking DNA constructs, then using conflicting results to identify what still needed to be resolved.
The cutaways are artistic interpretations. Colours, molecular movement and relative sizes are simplified for explanation; they are not experimental footage or a quantitative simulation. The enzyme model uses experimental coordinates from PDB 1NEK (E. coli, 2.6 Å), a reference for the four-subunit architecture, not a structure measured in Chloe’s project. The animated electron route connects cofactor positions schematically. DctA is an illustrative carrier: its exact topology, ion coupling and full transport cycle are not represented. The succinate symbol shows carbon and oxygen atoms, with hydrogen atoms omitted.
Project evidence: Chau Tran’s MSc dissertation, Results 4.1–4.2 and Discussion; the five-page expanded showcase. The later growth result is presented from the updated showcase; the dissertation predates this account. Original gel images and maps are reproduced unchanged.
Biological references: Wenner et al., 2024 — Salmonella succinate utilisation; Selak et al., 2005 — succinate and oxygen sensing; Yankovskaya et al., 2003 — SDH architecture; Salmonella flagellar anatomy; PubChem — succinate dianion.
Skills & experience
I’ve worked with clinical samples, investigated genetic variation and built bacterial DNA constructs. Here’s how I’ve used those techniques, what I learned and where I’d like to develop next.
Molecular biology
During my MSc at Swansea, I designed primers, optimised PCR and assembled a recombinant plasmid carrying dctA, a bacterial succinate-transporter gene. I screened candidate constructs using colony PCR and restriction digestion, then used sequencing to verify the insert’s identity and orientation. The sdhCDAB target was more difficult. I worked on amplification of the full operon and smaller fragments, then investigated unexpected inserts and possible plasmid instability. That work taught me to compare evidence from several methods and revise an experiment when the results did not match the design.
Techniques I can bring to a laboratory: DNA and plasmid extraction, PCR/qPCR, primer design, electrophoresis, bacterial culture, transformation, molecular cloning and construct screening.
Experience
I’ve worked in university research groups and diagnostic laboratories in Vietnam and the UK. Select a role to see what I worked on and the experience I can bring to a new team.
Bacterial engineeringJan 2025 – Jan 2026 · Swansea, UK
Swansea University
My MSc investigated bacterial succinate utilisation as part of a wider proposal to develop tumour-targeting Salmonella. I designed primers, optimised PCR and built pCT1, a plasmid carrying the dctA succinate-transporter gene. Sequencing verified the insert’s identity and orientation.
The sdhCDAB target proved more difficult. I used colony PCR, restriction digestion and sequencing to investigate unexpected inserts and possible plasmid instability. The project gave me substantial experience troubleshooting experiments and deciding what the evidence did—and did not—show.
Working together
I’m looking for laboratory and research roles in molecular diagnostics, microbiology and biomedical science, and PhD opportunities in cancer biology, immunology or computationally assisted research.
Based in Cardiff. Open to relocating for the right opportunity.
chloetran010501@gmail.com